Skip to content
With over 6 million unintended pregnancies in the U.S. each year and birth rates on the rise since 2021, making it easy to obtain […]
FDA approves first over-the-counter birth control pill Read More »
We see a great demand for effective therapies, particularly for conditions with limited treatment options. Transformative treatments, no matter how small, have the impact
3 things to know about the future of small molecule therapeutics Read More »
On July 17, Eli Lilly announced positive results from clinical trials of donanemab, the company’s candidate for the treatment of Alzheimer’s disease. The drug
Eli Lilly’s Alzheimer’s drug shows promise in slowing cognitive decline Read More »
In the latest bioscience victory over viruses, the Food and Drug Administration (FDA) on July 17 gave the first approval to a monoclonal antibody
FDA approves monoclonal antibody to protect infants from RSV Read More »
The challenge of preventing pharmacy benefit managers (PBMs) from driving up drug prices was front and center on Capitol Hill this week. Bipartisan legislation
Congress puts PBMs in the spotlight during a busy week on Capitol Hill Read More »
Sutro Biopharma, Inc., a clinical-stage drug discovery, development, and manufacturing company, has made significant advancements in the field of antibody-drug conjugates (ADCs). Their innovative
Sutro Biopharma in clinical stages for groundbreaking cancer treatment Read More »
With the deadly threat of drug-resistant infections increasing daily, we desperately need actions to address the broken commercial marketplace for novel antimicrobials—including the PASTEUR
Legislation to fight AMR superbugs is an urgent need, BIO member tells Senate hearing Read More »
The Senate Health, Education, Labor, and Pensions (HELP) Committee released a bipartisan discussion draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization bill
Senate HELP’s PAHPA draft: The good, the bad, and the ugly Read More »
Panelists came together in a session titled “Gene Therapy: Let’s Talk about Safety, Baby,” at the 2023 Biotechnology Innovation Organization (BIO) International Convention. Gene
Gene therapy: Let’s talk about safety Read More »
The U.S. Food and Drug Administration (FDA) granted traditional approval to the groundbreaking Alzheimer’s drug LEQEMBI, the first in a new class of Alzheimer’s
FDA grants traditional approval to LEQEMBI Read More »
